Atlas Trials

A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)

Clinical trial NCT03149991 · COMPLETED

Trial details

NCT number
NCT03149991
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Depression
Start date
2017-09-14
Primary completion
2019-03-31
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.